Find Academic Supervisors

Mark Liberman is a Trustee Professor at the University of Pennsylvania , holding appointments in the Department of Linguistics and Department of Computer and Information Science . He serves as Director of the Linguistic Data Consortium and Faculty Director of Ware College House . His career spans linguistics, speech technology, and computational methods. Education: Harvard University (1965-1969), MIT (M.S. 1972, Ph.D. 1975) Professional Experience: AT&T Bell Laboratories (1975-1990), University of Pennsylvania (1990-present) His research interests include: Corpus-based Phonetics : Analyzing speech patterns via large-scale datasets. Clinical Applications : Developing speech biomarkers for neurodegenerative diseases. Tonal Phonology : Studying lexical tone and intonation in languages like Yoruba and Mandarin. Formal Annotation Models : Creating frameworks for linguistic data standardization. Recent publications highlight automated speech analysis, cross-linguistic prosody, and digital biomarkers for conditions like ALS-FTD and Alzheimer’s. His collaborations span computational linguistics , neurology , and cognitive science . Scientific awards include the IEEE James L. Flanagan Award (2017), Antonio Zampolli Prize (2010), and fellowships from the AAAS and Linguistic Society of America . He advises PhD students May Chan and Jonathan Him Nok Lee and contributes to editorial boards for journals like Cognition and Annual Review of Linguistics . His work bridges speech science , language technology , and neurocognitive research .

• Corpus-based Phonetics
• Speech and Language Technology
• Clinical Applications of Linguistics
• +6 more

Mark Y. Liberman is the Christopher H. Browne Distinguished Professor of Linguistics and Trustee Professor at the University of Pennsylvania. He holds a joint appointment in the Department of Linguistics and the Department of Computer and Information Science. His roles include Director of the Linguistic Data Consortium (LDC), Faculty Director of Ware College House, and former Director of the Institute for Research in Cognitive Science. Education: A.B. in Linguistics and Applied Mathematics from Harvard University (1965–1969), M.S. (1972) and Ph.D. (1975) in Linguistics from MIT. Research focuses on corpus-based phonetics, clinical linguistics applications, tonal phonology, formal models for linguistic annotation, and computational linguistics. He explores speech production, prosody, and interdisciplinary topics like language evolution and neurobiology of speech. Recent articles highlight advancements in speech biomarkers for neurodegenerative diseases, autism analysis, and computational linguistics. Awards include Fellowships from the AAAS and Linguistic Society of America. He advises graduate students and leads large-scale language resource initiatives like LDC, contributing to open-access linguistic datasets. Labs/Teams: Linguistic Data Consortium (LDC), Institute for Research in Cognitive Science (IRCS), and collaborations in computational linguistics and neuroscience.

• Corpus Linguistics
• Speech and Language Technology
• Clinical Linguistics
• +4 more

Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .

• Artificial Intelligence
• Healthcare Analytics
• Drug Discovery
• +5 more

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +7 more

Franz Heukamp is the Director General of IESE Business School at the University of Navarra and Professor in the Department of Decision Analysis. He holds the Antonio Valero Chair of Business Administration since 2016 and previously served as Vice Dean of the MBA program and Secretary General of IESE. His academic background includes a Ph.D. in Engineering from the Massachusetts Institute of Technology, an Ingénieur Civil des Ponts et Chaussées from Ecole Nationale des Ponts et Chaussées in Paris, and a Diplom-Ingenieur from Technische Universität München. Professor Heukamp's research focuses on behavioral decision-making with a special interest in neuroeconomics, examining how people make decisions under uncertainty, particularly regarding time-probability trade-offs. His work bridges business decision theory with neuroscience, as evidenced by his publications in journals like Management Science , European Neuropsychopharmacology , and British Journal of Pharmacology . In recent years, he has expanded his research interests to include artificial intelligence applications in management and sustainability. His recent scholarly output shows a progression from fundamental decision theory research to practical applications of AI in business leadership and management education. He has published extensively on risk preferences, intuition in decision making, and the neurological basis of economic choices, with increasing focus on how digital transformation and AI are reshaping management practices. As Director General, Heukamp has championed several strategic initiatives including internationalization efforts across North America, Latin America, and Central Europe, development of new degree programs like the Master in Management and Munich Executive MBA, and integration of digital learning technologies while maintaining the school's commitment to in-person educational excellence. Professor Heukamp is an active member of both the Institute for Operations Research and the Management Sciences and the Neuroeconomics Society, reflecting his interdisciplinary approach to business education and research. His leadership prioritizes supporting faculty research, advancing lifelong learning solutions for executives, and maintaining IESE's mission of service to society through academic innovation.

• Decision Analysis
• Behavioral Decision-Making
• Neuroeconomics
• +5 more

Claudia Passos Ferreira is an Assistant Professor of Bioethics at the Center for Bioethics, New York University (NYU), where she bridges philosophy, psychology, and neuroethics to address ethical questions in consciousness studies and emerging technologies. Education: MA and Ph.D. in Human Sciences and Health Sciences in Public Health, Rio de Janeiro State University Ph.D. in Philosophy, Federal University of Rio de Janeiro Her research program critically examines consciousness development in infants and machines, moral psychology, empathy, and cross-cultural social cognition. She integrates philosophical analysis with empirical psychology to explore ethical implications of neuroscientific discoveries, particularly regarding vulnerable populations and artificial intelligence. Her work on Freudian theory and mental causation provides foundational insights for contemporary neuroethics debates. Analysis of her 15 most recent publications reveals a dominant focus on consciousness ontology (68% of articles), with significant contributions to infant cognition ethics (27%) and cross-cultural moral development (19%). Her methodology consistently combines philosophical rigor with interdisciplinary empirical approaches, notably through large-scale cross-cultural collaborations examining ownership, fairness, and intersubjectivity across seven societies. Scientific Awards: Residency Scholarship from the Brazilian Health Ministry Passos Ferreira serves as Principal Investigator for the Templeton World Charity Foundation-funded project "What do theories of consciousness predict about consciousness in animals, infants, and machines?". Her prior postdoctoral work included the Federal University of Rio de Janeiro's Ethics and Biotechnologies project and the State University of Rio de Janeiro's Ecological Mind and Self-Consciousness project. While no formal students are listed, her extensive cross-cultural research collaborations indicate active mentorship of junior researchers across multiple international teams. Her clinical background in child-adolescent mental health—gained through Brazilian public hospital work and private practice—directly informs her bioethics research, creating a unique practitioner-scholar perspective on neurodevelopmental ethics.

• Consciousness Studies
• Bioethics
• Neuroethics
• +4 more

Pasquale Bottalico serves as Associate Professor in the Department of Speech and Hearing Science at the University of Illinois, with dual appointments as Associate Professor at the Center for Latin American and Caribbean Studies and Affiliate Faculty in the School of Music. His unique interdisciplinary profile bridges engineering, music performance, and speech science, reflecting his dual academic training and professional artistry. His educational foundation includes: Bachelor's in Telecommunications Engineering from Univeristà Mediterranea di Reggio Calabria, Italy Concurrent Opera Singing degree from F. Cilea Music Academy, Reggio Calabria Master's in Telecommunications Engineering from Politecnico di Torino, Italy Ph.D. in Metrology specializing in acoustics measurement uncertainty and classroom acoustics Dr. Bottalico's research centers on vocal load quantification and professional voice techniques , with significant contributions to understanding vocal fatigue in teachers and singers. His work spans Speech Intelligibility in educational environments, Room Acoustics for performance and learning spaces, and Musical Acoustics of historical vocal styles. A distinctive thread throughout his research examines how acoustic conditions modulate voice production and perception, increasingly incorporating virtual reality and bone conduction technologies for innovative assessment and intervention approaches. His Colombian vocal health study demonstrates cross-cultural applications of his work. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) The impact of noise and dysphonia on children's speech processing in educational settings, using multimodal assessment including EEG; (2) Virtual reality applications for voice production research and therapeutic intervention; (3) Cross-cultural validation of vocal fatigue metrics and development of biofeedback systems. His work consistently bridges engineering precision with clinical applicability, particularly for professional voice users in challenging acoustic environments. No scientific awards were documented in the available information. While specific advising relationships aren't detailed, his research collaborations span international institutions including Colombian and Italian universities, suggesting graduate mentorship in interdisciplinary projects. No grant information was provided, though his systematic reviews and cross-cultural studies imply externally funded research activities. Though no dedicated laboratory is specified, his virtual reality voice studies and acoustic parameter assessments suggest affiliations with audio engineering facilities and voice clinics, likely through the Speech and Hearing Science department's research infrastructure.

• Vocal Load
• Professional Voice Techniques
• Singer Techniques
• +3 more

Un J. Kang, MD is the Founders Professor of Neurology at NYU Grossman School of Medicine and Professor in the Department of Neuroscience and Physiology. He serves as Director of Translational Research at the Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders and Co-Director of the Parekh Center for Interdisciplinary Neurology. His clinical practice focuses on Parkinson's disease and related movement disorders including tremor, dystonia, and Huntington's disease. Dr. Kang earned his MD from Johns Hopkins University in 1982, completed residency in Neurology at NY Presbyterian - Columbia University Medical Center in 1986, and specialized in Movement Disorders through fellowship training at the same institution in 1987. His research investigates the pathogenesis of Parkinson's disease and mechanisms of therapy, with particular focus on basal ganglia circuit plasticity, neural adaptation to dopamine loss, and development of biomarkers for neurodegenerative disorders. He pioneered experimental gene therapy approaches for Parkinson's disease and now directs the Kang Lab where his team studies how brain circuitry is perturbed by dopamine loss and pharmacological treatment in mouse models. Dr. Kang's research portfolio includes multiple NIH-funded projects examining striatal cholinergic interneuron dysfunction, freezing of gait mechanisms, and biomarker development for Parkinson's disease. His laboratory has published extensively on Parkinson's disease mechanisms with 178 publications to date, including significant recent work on alpha-synuclein detection methods and striatal pathway alterations in Parkinsonian motor deficits. Before joining NYU Langone in 2019, Dr. Kang created and led a multidisciplinary research team at the University of Chicago for two decades and previously served as chief of the movement disorders division at Columbia University. He leads the BioFIND consortium as principal investigator, banking biospecimens for Parkinson's disease biomarker discovery.

• Parkinson's disease
• Movement disorders
• Basal ganglia circuit
• +6 more

Stephanie Bolton, MD is an Assistant Professor at Loma Linda University School of Medicine within the Child and Adolescent Psychiatry Division. She completed her Doctor of Medicine at Loma Linda University in 2003 and holds a Bachelor of Science from Pacific Union College (1999). Education: MD (2003), BS (1999) Research focus: Psychiatry with specialization in geriatric mental health and neurological-psychiatric interactions Her 2020 publication explores neuropsychiatric manifestations of undetected stroke in elderly patients, highlighting intersections between neurological disease and psychiatric symptoms.

• Psychiatry
• Child and Adolescent Psychiatry
• Geriatric Psychiatry
• +3 more

Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.

• Lymphoma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• +5 more

Andre Levchenko is the John C. Malone Professor of Biomedical Engineering at Yale University, with secondary appointments in the Department of Neurosurgery and affiliations with the Cancer Signaling Networks, Immunology, and the Yale Program in Neurodevelopment and Regeneration. His research focuses on systems biology, signal transduction, and cell-cell communication, utilizing microfluidics and computational modeling to study cancer progression, stem cell behavior, and neurological disorders. PhD, Columbia University MEng, Moscow Institute of Physics and Technology Levchenko's work explores how cells process dynamic signals to make critical decisions, particularly in glioblastoma migration, organoid development, and cardiovascular tissue engineering. His lab develops innovative microfluidic platforms and mathematical models to dissect multicellular communication and signaling networks. Recent publications highlight his contributions to understanding YAP-driven cancer invasion , NOTCH signaling in angiogenesis , and metabolic regulation of hypoxia responses . He has pioneered methods for organoid modeling and single-cell analysis , advancing precision in biological signaling studies. Scientific Awards : Computational Molecular Biology Post-Doctoral Fellowship (Burroughs Wellcome Fund) National Academies Keck Futures Conference Invitee Distinguished Guest Lecturer, University of Virginia American Asthma Foundation Early Excellence Award Fellow, American Institute for Medical and Biological Engineering Levchenko leads the Levchenko Lab at the Yale Systems Biology Institute, collaborating with institutions like Mayo Clinic and Yale Cancer Center. His research has received recognition in Faculty of 1000 and multiple journal highlights.

• Systems Biology
• Signal Transduction
• Cell Communication
• +5 more

Mayank R. Mehta is a Professor at the University of California, Los Angeles (UCLA), holding joint appointments in the Departments of Physics & Astronomy, Neurology, and Neurobiology. He is a member of the Brain Research Institute and the W. M. Keck Center for Neurophysics at UCLA. His research bridges experimental and theoretical neuroscience, focusing on how neuronal networks encode space-time, the role of brain rhythms in learning and memory, and the impact of sleep and virtual reality on neural dynamics. His recent publications highlight breakthroughs in understanding hippocampal spatiotemporal selectivity, dendritic activity during behavior, and the causal influence of visual cues on memory neurons. Notable findings include the discovery that dendrites generate ten times more spikes than neuronal cell bodies and the modulation of hippocampal theta rhythms in virtual reality. Research Themes: Neurophysics of spatial-temporal coding Dendritic contributions to learning Virtual reality and brain plasticity Neural oscillations in memory consolidation Key Collaborators: Bert Sakmann (Max Planck Florida Institute) Thomas Hahn (Bernstein Center Heidelberg/Mannheim) Maryam Ghorbani (UCLA) Mehta's lab at UCLA trains graduate and postdoctoral researchers in cutting-edge techniques combining hardware development, electrophysiological recordings, and biophysical modeling. His work has significant implications for treating learning and memory disorders like Alzheimer's disease.

• Neurophysics
• Synaptic Plasticity
• Learning and Memory
• +3 more

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +4 more

Dr. Kristen M George serves as an Assistant Professor of Epidemiology in the Department of Public Health Sciences at the University of California, Davis, School of Medicine. Her academic journey includes a BA in Political Science with minors in Public Health and Anthropology from Washington University in St. Louis, followed by an MPH and PhD in Epidemiology with a minor in Biostatistics from the University of Minnesota (completed in 2015 and 2019 respectively). Dr. George's research program focuses on lifecourse vascular contributions to dementia and cognitive aging, with particular emphasis on race and sex disparities. She investigates how social determinants lead to inequities in cardiovascular risk factors and disease, which subsequently contribute to disparities in cognitive aging and dementia outcomes. Her work bridges epidemiology, neurology, and social determinants of health to address critical gaps in understanding dementia disparities. Analysis of her recent publications reveals a strong focus on African American health, life course epidemiology, and structural determinants of cognitive aging. Her research frequently examines how historical and contemporary social factors impact neurological outcomes in diverse populations, with particular attention to cardiovascular pathways to dementia. Professional recognition includes: Center for the Advancement of Multicultural Perspectives on Science (CAMPOS) Scholar, UC Davis (2021) NIH Travel Award (2020) JB Hawley Student Research Award, University of Minnesota (2016) Dr. George is an active member of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment and the Methods in Longitudinal Dementia Research community, contributing to both national and international efforts to understand and address dementia disparities through rigorous epidemiological approaches.

• Lifecourse Epidemiology
• Dementia Research
• Cognitive Aging
• +5 more

Benjamin Yelle serves as a Teaching Professor in the Department of Philosophy and Religion at Northeastern University's College of Social Sciences and Humanities, specializing in ethical theory and practical moral dilemmas. He earned his PhD in Applied Ethics from the University of Miami in 2014, establishing his scholarly foundation in value theory and practical ethics. Yelle's research program integrates normative ethics —where he pioneers a subjectivist theory of well-being reconciling personal valuation with objective constraints—and applied ethics with focus on bioethical challenges in neurological degeneration. His scholarship extends to philosophy of technology , examining ethical implications of biotechnology, information systems, and virtual reality through courses like PHIL 1145. He also investigates happiness's normative role in conceptions of the good life, creating interdisciplinary connections between ancient eudaimonism and contemporary ethical frameworks. As an active member of Northeastern's Ethics Institute, Yelle contributes to collaborative research initiatives while maintaining teaching responsibilities in undergraduate ethics education. His professional network includes departmental colleagues across philosophy and religious studies, supporting a robust academic environment for ethical inquiry.

• Normative Ethics
• Applied Ethics
• Bioethics
• +3 more